Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-06

Clinical Trial Update: Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a combination of palonosetron, ondansetron, and dexamethasone for preventing delayed chemotherapy-induced nausea and vomiting in autolo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)
  • Ondansetron (ondansetron)
  • Palonosetron (palonosetron)

Snippet

Sponsor: Northside Hospital, Inc. | Conditions: Chemotherapy-induced Nausea and Vomiting | Phase 2 | Status: COMPLETED | Results posted: 2017-02-06